Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201304114 Principal Investigator: Bartlett, Nancy
Title: An Open-Label Treatment Use Protocol for Ibrutinib (PCI-32765) in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Phase: N/A Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to provide patients who have relapsed or refractory Mantle Cell Lymphoma with early access to an investigational drug called ibrutinib and to collect safety information about the drug.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)